GlassScriptPhysician profile
Kevin P Hogan
NPI 1497730139
$1,811.43
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,221 · 2020: $591.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $552.81 | 2019-2020 | |
| Pfizer INC. | $159.28 | 2019-2020 | |
| Dermira, INC. | $129.28 | 2019 | |
| Genzyme Corporation | $117.31 | 2019 | |
| Abbvie INC. | $116.26 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $90.88 | 2019-2020 | |
| Biofrontera INC. | $85.23 | 2019-2020 | |
| Janssen Biotech, INC. | $71.59 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $68.13 | 2019 | |
| Novartis Pharmaceuticals Corporation | $55.44 | 2019-2020 | |
| Lilly USA, LLC | $55.43 | 2019-2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $53.05 | 2019-2020 | |
| Almirall LLC | $49.88 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $49.05 | 2019 | |
| Leo Pharma INC. | $41.07 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vyne Pharmaceuticals INC. | $39.66 | 2020 | |
| Celgene Corporation | $23.65 | 2019 | |
| Janssen Scientific Affairs, LLC | $22.38 | 2020 | |
| Epi Health, LLC | $16.70 | 2020 | |
| Allergan, INC. | $14.35 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Hogan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.